Latvian national focal point

This report explains how the Reitox Alliance and the European Union Drugs Agency (EUDA) will work together under the Agency’s new mandate.

Harm reduction encompasses interventions, programmes and policies that seek to reduce the health, social and economic harms of drug use to individuals, communities and societies. On this page, you can find the latest analysis of harm reduction interventions in Europe, including key data on o

Drug-induced deaths are those that are directly attributable to the use of drugs. On this page, you can find the latest analysis of drug-induced deaths in Europe, including key data on overdose deaths, the substances implicated and more. 

Opioid users represent the largest group undergoing specialist drug treatment, mainly in the form of opioid agonist treatment.

People who inject drugs are at risk of contracting infections through the sharing of drug use paraphernalia. On this page, you can find the latest analysis of drug-related infectious diseases in Europe, including key data on infections with HIV and hepatitis C, B and A viruses.

Despite a continued decline in injecting drug use over the past decade in the European Union, this behaviour is still responsible for a disproportionate level of both acute and chronic health harms associated with the consumption of illicit drugs.&nb